Details for Patent: 9,586,955

✉ Email this page to a colleague

Which drugs does patent 9,586,955 protect, and when does it expire?

Patent 9,586,955 protects EVRYSDI and is included in one NDA.

This patent has forty-nine patent family members in twenty-nine countries.

Summary for Patent: 9,586,955

Patent landscape, scope, and claims:

Title:	Compounds for treating spinal muscular atrophy
Abstract:	Provided herein are compounds of Formula (I): ##STR00001## and forms thereof, including compositions thereof and uses therewith for treating spinal muscular atrophy.
Inventor(s):	Qi; Hongyan (Plainsboro, NJ), Choi; Soongyu (Belle Mead, NJ), Dakka; Amal (Whitehouse Station, NJ), Karp; Gary Mitchell (Princeton Junction, NJ), Narasimhan; Jana (Scotch Plains, NJ), Naryshkin; Nikolai (East Brunswick, NJ), Turpoff; Anthony A. (Hillsborough, NJ), Weetall; Marla L. (Morristown, NJ), Welch; Ellen (Califon, NJ), Woll; Matthew G. (Dunellen, NJ), Yang; Tianle (Mountainside, NJ), Zhang; Nanjing (Princeton, NJ), Zhang; Xiaoyan (Belle Mead, NJ), Zhao; Xin (Belle Mead, NJ), Green; Luke (Basel, CH), Pinard; Emmanuel (Linsdort, FR), Ratni; Hasane (Habsheim, FR)
Assignee:	PTC Therapeutics, Inc. (South Plainfield, NJ) F. Hoffmann-La Roche AG (Basel, CH)
Application Number:	14/377,531
Patent Claim Types: see list of patent claims	Composition; Compound;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 9,586,955

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Genentech Inc	EVRYSDI	risdiplam	FOR SOLUTION;ORAL	213535-001	Aug 7, 2020		RX	Yes	Yes	9,586,955	⤷ Subscribe	Y	Y			⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,586,955

PCT Information
PCT Filed	February 08, 2013	PCT Application Number:	PCT/US2013/025292
PCT Publication Date:	August 15, 2013	PCT Publication Number:	WO2013/119916

International Family Members for US Patent 9,586,955

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	092794	⤷ Subscribe
Australia	2013216870	⤷ Subscribe
Australia	2017204248	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.